Global Medical REIT Inc.GMRE

Market cap
$2.4B
P/E ratio
Aug 31,
2012
Aug 31,
2013
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income-50,108-45,338-------20227
Depreciation, Total--659,6712814192734404140
Amortization of Leased Asset------61013171714
Amortization of above market leases, net----99401111111
Amortization of Other Deferred Charges------112222
Share-based Compensation---223356545
Noncash Merger Related Costs----00000000
Reserve for uncollectible accounts-------10-11
Gain on sale of investment properties--------17164
Impairment of investment property-----------2
Equity loss from unconsolidated joint venture-----------0
Loss on extinguishment of debt-----------1-
Other-------00-0-0-0-0
Tenant receivables---212,435022213-01
Deferred assets---93,646681,24236565432
Other assets and liabilities----0000-0-1-1-2
Accounts payable and accrued expenses----39,509121224-23
Security deposits---719,592122001-2-0
Net cash provided by operating activities-35,108-33,794-208,801-1225363569776870
Purchase of land, buildings, and other tangible and intangible assets and liabilities---150252181255218192151082
Proceeds From Sale Of Investment Property--------5187957
Investment in unconsolidated joint venture-----------2
Escrow deposits for purchase of properties----104,3100-01-0-2-0-0
Advances made to related parties---137,7270-0-00-0-00-0
Payment received on loan made to a tenant---------1--
Capital expenditures on existing real estate investments-----------13
Leasing commissions----------16
Net cash used in investing activities---32,338,990--253-152-258-224-195-13768-46
Proceeds from Issuance of Common Stock55,00080,000--34371895320610-11
Escrow deposits required by third party lenders----------70
Repayment of notes payable--349,435------1112
Payment for CMBS loan defeasance----------32-
Proceeds from Credit Facility---28-18624423822213983144
Repayment of Credit Facility-----711736522416136100
Payment of debt issuance costs-------163--
Dividends paid to common stockholders, and OP Unit and LTIP Unit holders-------4053585960
Dividends paid to preferred stockholders---416666666
Net cash provided by financing activities55,38080,38041,643,255-22612522419312862-144-22
Net (decrease) increase in cash and cash equivalents and restricted cash------22422-82
Interest Paid, Net--1,165,1574613161718223027
Liabilities Assumed---467111216161617
Interest rate swap agreements fair value change recognized in other comprehensive income-------12-12-41107
Units Converted To Common Stock-------181101
Capital Expenditures Incurred but Not yet Paid----11161-1122
Stock Issued---30------5-
Loans Assumed-------12-2--
Notes Reduction----------0-